Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05936099
Other study ID # STUDY00002116
Secondary ID 5K23DA055736-02
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date July 10, 2025

Study information

Verified date January 2024
Source Children's Mercy Hospital Kansas City
Contact Abbey Masonbrink, MD, MPH
Phone 816-802-3236
Email armasonbrink@cmh.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to develop and evaluate an evidence-based intervention to assist adolescents and young adults with current vaping to quit vaping and smoking.


Description:

Use of electronic nicotine delivery system (ENDS), which are noncombustible tobacco products (e.g., e-cigarettes), has increased dramatically among youth and is associated with numerous adverse health outcomes as well as use of alcohol and other illicit substances. National guidelines recommend counseling to address tobacco use at every adolescent clinical visit; however, many at-risk adolescents do not routinely attend primary care. Although evidence supports treatment of tobacco use during an adult hospitalization, no interventions have been developed or tested in the pediatric hospital setting. Based on promising theoretically-based evidence from the primary care and hospital settings, we will design, iteratively refine and assess implementation of a novel tobacco and ENDS use intervention for hospitalized adolescents and young adults (AYAs). We do so by conducting a randomized controlled pilot study (n=144) with 3-month follow up to evaluate preliminary efficacy as well as implementation outcomes (i.e., acceptability, feasibility, fidelity).


Recruitment information / eligibility

Status Recruiting
Enrollment 144
Est. completion date July 10, 2025
Est. primary completion date July 10, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 14 Years to 21 Years
Eligibility Inclusion Criteria: - Admitted to the hospital - Screens positive for past 30 day e-cigarette use - Parent/guardian agrees to leave the room Exclusion Criteria: - Age is less than 14 years or over 21 years - Not comfortable speaking/reading English - Too ill to participate - Severe psychiatric illness - Too developmentally delayed/cognitively impaired

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
E-cigarette & Tobacco Use Treatment Intervention
The behavioral intervention includes health education on vaping health risk and outcomes, motivational interviewing, and assisted quit planning from a health educator and counseling and nicotine replacement therapy (if appropriate) provided by a physician.

Locations

Country Name City State
United States Children's Mercy Hospital Kansas City Missouri

Sponsors (3)

Lead Sponsor Collaborator
Children's Mercy Hospital Kansas City National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Self-reported 30-day abstinence Cessation verified with biochemical verification of a saliva sample 3 month follow up
Secondary Acceptability of intervention in pediatric inpatient hospital setting Ratings from participants, participants' parent, and providers on perceived acceptability (i.e., satisfaction) of the intervention End of study (enrollment completion)
Secondary Feasibility of intervention Ratings from participants, participants' parent, and providers on perceived feasibility (i.e., utility or practicability) of the intervention End of study (enrollment completion)
Secondary Fidelity of intervention delivered by a health educator Extent of fidelity achieved in intervention delivery End of study (enrollment completion)
See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02649556 - A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 N/A
Completed NCT03901066 - Smoking Dependence and Periodontitis
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT03305978 - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. N/A
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability N/A
Active, not recruiting NCT02752022 - Monitoring the Transition From Smoking to E-cigarettes
Completed NCT04340830 - The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants N/A
Completed NCT02912000 - TEACH: Technology Evaluation to Address Child Health N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02901171 - The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation N/A
Completed NCT02949648 - Electronic Cigarette Use and Quitting in Youth N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT02246114 - Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women N/A
Completed NCT01898507 - Nicotine Metabolism and Low Nicotine Cigarettes N/A
Completed NCT02008292 - Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors N/A
Completed NCT01954407 - Young Adults' Responses to Anti-smoking Messages N/A